title: Heterogeneity of breast cancer: etiology and clinical relevance.
abstract: Cancer progression is a dynamic process of clonal adaptation to changing microenvironments. From the single founder cell until the clinical detection of tumours, there are consecutive clonal expansions and a constant acquisition of genetic and epigenetic alterations, events that contribute to the generation of intra-tumor heterogeneity. In breast cancer intra-tumor heterogeneity can arise from the differentiation of stem-like cells along with the clonal selection during tumor progression, and represents a major challenge for the design of effective therapies. To infer breast cancer progression and its response to particular treatments it is important to understand the origins of the inter- and intra-tumor heterogeneity and the forces that control tumor evolution. Insights about the evolution of breast cancer heterogeneity would contribute to the design of most effective therapeutic strategies to target the tumors at single clon level. This review is intended to give a general overview about the origins of breast cancer heterogeneity and its impact in the clinical management of the disease.
authors.affiliation: Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Centro Esther Koplowitz (CEK), Servicio de Oncología Médica, Hospital Clínic, Universitat de Barcelona, Spain. almendro@clinic.ub.es
authors.forename: V
authors.initials: V
authors.lastname: Almendro
authors.forename: G
authors.initials: G
authors.lastname: Fuster
mesh_terms: D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000209:etiology* / Q000235:genetics* / Q000473:pathology; D002454:Cell Differentiation; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology
references.citation: Breast Cancer Res Treat. 2011 Sep;129(2):635-43
references.pmid: 21617917
references.citation: Hum Mol Genet. 2011 Aug 15;20(16):3289-303
references.pmid: 21596841
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
references.pmid: 19666588
references.citation: Nature. 2007 Oct 4;449(7162):557-63
references.pmid: 17914389
references.citation: Breast J. 2007 Mar-Apr;13(2):122-9
references.pmid: 17319852
references.citation: Nat Rev Cancer. 2004 Oct;4(10):814-9
references.pmid: 15510162
references.citation: Cancer Res. 2004 Feb 1;64(3):830-5
references.pmid: 14871808
references.citation: J Clin Invest. 2011 Jul;121(7):2723-35
references.pmid: 21633165
references.citation: Eur J Cancer. 2008 Dec;44(18):2760-5
references.pmid: 19026532
references.citation: Genome Biol. 2007;8(5):R76
references.pmid: 17493263
references.citation: Breast Cancer Res. 2008;10(3):R53
references.pmid: 18559090
references.citation: J Cell Biol. 2007 Apr 9;177(1):87-101
references.pmid: 17420292
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Nature. 2008 Dec 4;456(7222):593-8
references.pmid: 19052619
references.citation: Hum Mol Genet. 2001 Apr;10(7):705-13
references.pmid: 11257103
references.citation: Ann N Y Acad Sci. 1956 Mar 14;63(5):818-30
references.pmid: 13314436
references.citation: Nature. 2011 Jan 20;469(7330):314-22
references.pmid: 21248838
references.citation: Nat Rev Cancer. 2006 Dec;6(12):924-35
references.pmid: 17109012
references.citation: Cancer Prev Res (Phila). 2010 Nov;3(11):1361-4
references.pmid: 20959519
references.citation: Genes Dev. 2009 Nov 15;23(22):2563-77
references.pmid: 19933147
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
references.pmid: 12829800
references.citation: Biochim Biophys Acta. 2010 Jan;1805(1):105-17
references.pmid: 19931353
references.citation: Clin Cancer Res. 2010 Feb 1;16(3):876-87
references.pmid: 20103682
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1397-402
references.pmid: 21220315
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Breast Cancer Res. 2010;12(5):R68
references.pmid: 20813035
references.citation: Nat Med. 1997 Jul;3(7):730-7
references.pmid: 9212098
references.citation: J Clin Invest. 2007 Nov;117(11):3155-63
references.pmid: 17975657
references.citation: Br J Cancer. 2011 May 24;104(11):1730-8
references.pmid: 21559013
references.citation: Cell Stem Cell. 2010 Sep 3;7(3):403-17
references.pmid: 20804975
references.citation: Cancer Cell. 2007 Mar;11(3):259-73
references.pmid: 17349583
references.citation: Breast Cancer Res Treat. 2005 Mar;90(1):5-14
references.pmid: 15770521
references.citation: Nat Med. 2009 Aug;15(8):907-13
references.pmid: 19648928
references.citation: Ann Oncol. 2008 Mar;19(3):595-7
references.pmid: 18272907
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Cell. 2011 Jun 10;145(6):926-40
references.pmid: 21663795
references.citation: J Clin Oncol. 2006 May 10;24(14):2137-50
references.pmid: 16682732
references.citation: Cancer Res. 2011 Jul 1;71(13):4640-52
references.pmid: 21712410
references.citation: Exp Cell Res. 2004 Jul 15;297(2):444-60
references.pmid: 15212947
references.citation: Lab Invest. 2002 Nov;82(11):1525-33
references.pmid: 12429812
references.citation: Cell. 2010 Jan 8;140(1):62-73
references.pmid: 20074520
references.citation: Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5
references.pmid: 21498687
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5
references.pmid: 18230721
references.citation: Am J Clin Pathol. 2009 May;131(5):678-82
references.pmid: 19369627
references.citation: Cancer Res. 2010 Jun 1;70(11):4624-33
references.pmid: 20484027
references.citation: Cancer Cell. 2008 May;13(5):394-406
references.pmid: 18455123
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: Breast Cancer Res. 2010;12(6):R94
references.pmid: 21067584
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Br J Cancer. 2010 Oct 12;103(8):1139-43
references.pmid: 20877357
references.citation: Cell Stem Cell. 2011 Feb 4;8(2):149-63
references.pmid: 21295272
references.citation: Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a003244
references.pmid: 20591988
references.citation: Int J Oncol. 2006 Oct;29(4):935-45
references.pmid: 16964389